VCM
IHE icon

Virtue Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Virtue Capital Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.43M Buy
+76,344
New +$6.68M 0.98% 25
2024
Q2 		– Sell
-77,546
Closed -$4.98M – 403
2024
Q1 		$4.98M Buy
+77,546
New +$5.13M 0.89% 25

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Virtue Capital Management's IHE Position: Q1 2026 in Review

Virtue Capital Management opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q1 2026: 76,344 shares worth $6.43M. The stake represents 0.98% of the portfolio and ranks #25 among its holdings. This is a return to the name: Virtue Capital Management previously reported a position in IHE as recently as Q1 2024.

Virtue Capital Management first reported a position in IHE in Q1 2024 and has held it in 2 quarters since. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Virtue Capital Management held 76,344 shares of iShares US Pharmaceuticals ETF worth $6.43M as of Q1 2026.
  • iShares US Pharmaceuticals ETF was a new Virtue Capital Management position in Q1 2026.
  • iShares US Pharmaceuticals ETF made up 0.98% of Virtue Capital Management's portfolio in Q1 2026, its #25 holding.
  • Virtue Capital Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2024 and has held it in 2 quarters since.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Virtue Capital Management's 13F filing for Q1 2026, filed 7 May 2026.